Abnormal scaffold attachment factor 1 expression and localization in spinocerebellar ataxias and Huntington’s chorea

Autor: Andriana Gialeli, Nicola Buckner, Liang-Fong Wong, Kevin C Kemp, Caroline A Rivers, Nicholas D. Allen, Helen L. Scott, Alastair Wilkins, Gongyu Shi, James B. Uney, Oscar Cordero-Llana
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Cerebellum
Parkinson's disease
Purkinje cell
Purkinje Cells
spinocerebellar ataxia
0302 clinical medicine
Nuclear Matrix-Associated Proteins
Research Articles
Huntington’s chorea
Aged
80 and over

Neurons
General Neuroscience
Brain
Parkinson Disease
Middle Aged
Cell biology
Huntington Disease
medicine.anatomical_structure
Receptors
Estrogen

Spinocerebellar ataxia
Female
medicine.symptom
Research Article
Multiple Sclerosis
Substantia nigra
Huntington's chorea
Biology
Pathology and Forensic Medicine
03 medical and health sciences
medicine
Humans
Spinocerebellar Ataxias
Aged
SAFB1
RNA binding protein (RBP)
Chorea
Matrix Attachment Region Binding Proteins
medicine.disease
Corpus Striatum
030104 developmental biology
Dentate nucleus
nervous system
Parkinson’s disease
Neurology (clinical)
Trinucleotide repeat expansion
polyglutamine
Nucleus
030217 neurology & neurosurgery
Zdroj: Buckner, N, Kemp, K C, Scott, H L, Shi, G, Rivers, C A, Gialeli, A, Wong, L-F, Cordero Llana, O, Allen, N, Wilkins, A & Uney, J B 2020, ' Abnormal scaffold attachment factor 1 expression and localisation in spinocerebellar ataxias and huntington’s chorea ', Brain Pathology . https://doi.org/10.1111/bpa.12872
Brain Pathology
ISSN: 1750-3639
1015-6305
Popis: SAFB1 is a DNA and RNA binding protein that is highly expressed in the cerebellum and hippocampus and is involved in the processing of coding and non‐coding RNAs, splicing and dendritic function. We analyzed SAFB1 expression in the post‐mortem brain tissue of spinocerebellar ataxia (SCA), Huntington’s disease (HD), Multiple sclerosis (MS), Parkinson’s disease patients and controls. In SCA cases, the expression of SAFB1 in the nucleus was increased and there was abnormal and extensive expression in the cytoplasm where it co‐localized with the markers of Purkinje cell injury. Significantly, no SAFB1 expression was found in the cerebellar neurons of the dentate nucleus in control or MS patients; however, in SCA patients, SAFB1 expression was increased significantly in both the nucleus and cytoplasm of dentate neurons. In HD, we found that SAFB1 expression was increased in the nucleus and cytoplasm of striatal neurons; however, there was no SAFB1 staining in the striatal neurons of controls. In PD substantia nigra, we did not see any changes in neuronal SAFB1 expression. iCLIP analysis found that SAFB1 crosslink sites within ATXN1 RNA were adjacent to the start and within the glutamine repeat sequence. Further investigation found increased binding of SAFB1 to pathogenic ATXN1‐85Q mRNA. These novel data strongly suggest SAFB1 contributes to the etiology of SCA and Huntington’s chorea and that it may be a pathological marker of polyglutamine repeat expansion diseases.
Databáze: OpenAIRE